Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis

• Main Authors: Ali Yousefian-Jazi, YunHee Seol, Jieun Kim, Hannah L. Ryu, Junghee Lee, Hoon Ryu
• Format: Article
• Language: English
• Published: MDPI AG 2020-12-01
• Series: Cells
• Subjects: amyotrophic lateral sclerosis; motor neuron; genome signature; cell damage; neurodegeneration
• Online Access: https://www.mdpi.com/2073-4409/9/12/2687

Amyotrophic lateral sclerosis (ALS) is the most frequent motor neuron disease and a neurodegenerative disorder, affecting the upper and/or lower motor neurons. Notably, it invariably leads to death within a few years of onset. Although most ALS cases are sporadic, familial amyotrophic lateral sclerosis (fALS) forms 10% of the cases. In 1993, the first causative gene (<i>SOD1</i>) of fALS was identified. With rapid advances in genetics, over fifty potentially causative or disease-modifying genes have been found in ALS so far. Accordingly, routine diagnostic tests should encompass the oldest and most frequently mutated ALS genes as well as several new important genetic variants in ALS. Herein, we discuss current literatures on the four newly identified ALS-associated genes (<i>CYLD</i>, <i>S1R</i>, <i>GLT8D1</i>, and <i>KIF5A</i>) and the previously well-known ALS genes including <i>SOD1</i>, <i>TARDBP</i>, <i>FUS</i>, and <i>C9orf72</i>. Moreover, we review the pathogenic implications and disease mechanisms of these genes. Elucidation of the cellular and molecular functions of the mutated genes will bring substantial insights for the development of therapeutic approaches to treat ALS.